Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients
NCT00299091
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
Efavirenz capsules 200 mg and 600 mg
Sponsor
Germans Trias i Pujol Hospital